4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-23-041553
President, CMO gave up 3,242 shares (to pay taxes)
- President, CMO acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huang Jane President, CMO | 2023-07-04 | Option exercise | +9,375 | 33,595 | D | ||
| Huang Jane President, CMO | 2023-07-04 | Shares withheld for taxes | −3,242 | $4.65 | $15,075 | 30,353 | D |
| Derivatives | |||||||
| Huang Jane President, CMO | 2023-07-04 | Option exercise · Restricted Stock Unit | −9,375 | 103,125 | D | ||
Loading xslF345X04/doc4.xml…